Existence Of Cardiovascular Risk Factors Research Articles

Elderly Individuals Residing in Nursing Homes in Western Romania Who Have Been Diagnosed with Hearing Loss are at a Higher Risk of Experiencing Cognitive Impairment.

The objective of this research was to determine if there is any correlation between the severity of neurocognitive disorder and hearing impairment in the elderly. This is a population-based observational study that included subjects aged ≥ 65 years. They were evaluated for the existence of cardiovascular risk factors, diabetes, stroke, alcohol abuse, and smoking. Hearing impairment was diagnosed by an audiologist, using behavioral audiometric examination. These evaluations might have been performed in response to concerns about hearing loss, or they could have been a routine component of yearly comprehensive health screenings that included a Mini-Mental State Examination 2nd Edition (MMSE-2) test. According to the results of the MMSE-2 scale, we divided the individuals into two groups, Group I for those who had cognitive impairment and severe neurocognitive disorder, and Group II for those who did not have cognitive impairment. The study enrolled 203 patients with a mean age of 77 ± 7.5 years (range 65-98), 99 (48%) were males. When comparing the two groups, group I patients presented more often cardiovascular risk factors, stroke, diabetes, and impaired hearing. The univariable logistic regression found that cognitive impairment was significantly more frequent in the elderly with cardiovascular disease, diabetes, and stroke (p<0.0001). The multivariate regression analysis found that stroke (p<0.0001) diabetes (p=0.0008), cardiovascular disease (p=0.0004), and impaired hearing (p=0.0011) were significantly linked to cognitive impairment. The occurrence of hearing impairment in the elderly was related to having an MMSE-2 score of 14 or below. According to the findings of this research, the elderly who have trouble hearing in addition to other conditions might have an increased risk for severe neurocognitive disorder.

Is Aspirin the True Protective Therapy in Coronavirus Disease 2019 Patients?

To the Editor With their recent article, Chow et al1 make an important contribution to the knowledge of the promising therapeutic pathways for severe forms of coronavirus disease 2019 (COVID-19) infection. If their findings are confirmed, aspirin could represent the most widely available tool to reduce the burden of this disease, especially in low-income countries in which more expensive agents, such immunomodulators,2 are not available for most of the patients. Even though the authors acknowledge some limitations due to the design of this retrospective cohort, they seem to have missed some important adjustments that could explain the apparent favorable effect of aspirin in their study. In fact, the chronic use of aspirin in the included patients is mainly driven by the existence of cardiovascular risk factors and/or overt coronary disease such as depicted in Table 1. Surprisingly, the authors did not provide any information concerning the rate of patients under statin or angiotensin-converting enzyme (ACE) inhibitors in their study. Such treatments are largely coprescribed in these clinical situations. Interestingly, several large cohorts have specifically highlighted the favorable effect of those medications on COVID-19 outcomes,3–5 making it essential to adjust the results on the basis of these data before reporting any conclusive independent effect of aspirin. Jean-Jacques Mourad, MD, PhDJaehyo Suhl, MDDepartment of Internal Medicine and European Society of Hypertension Excellence CentreGroupe hospitalier Paris Saint-JosephParis, France[email protected]

Fisioterapia preventiva cardiovascular: Relato de experiência

Introduction: Cardiovascular diseases contribute to the increase in morbidity and mortality rates, loss of quality of life and increase in public spending. Objectives: To promote educational action through a lecture on prevention and correction of cardiovascular risk factors aimed at CRAS participants Nezinho Guida, Setor Vila Iris, Gurupi-TO. Methodology: Experience report on primary performance directed to individuals over 18 years of age, of both sexes. After CRAS authorization, the participants underwent an initial lecture to explain the action and its importance. Secondly, anthropometric measurements (weight, height, blood pressure, heart rate) and an evaluation form were checked to check for the presence of cardiovascular risk factors. They were submitted weekly to lectures and preventive guidelines for cardiovascular diseases, followed by the measurement of vital data before and after group physical exercises. Results: It can be inferred that the action contributed to greater clarification of the participants, where the presence of risk factors for atherosclerotic diseases was detected. Final considerations: It can be inferred that the existence of cardiovascular risk factors constitutes an important public health problem, which demonstrates the importance of educational actions in primary prevention. Keywords: Risk factors. Cardiovascular diseases. Prevention of diseases. Physiotherapy.

GUT MICROBIOTA AND ITS RELATIONS WITH CARDIOVASCULAR RISK FACTORS IN ALMOST HEALTHY INHABITANTS OF MOSCOW AND MOSCOW REGION

Aim. To investigate on the relation of microbiota content and cardiovascular risk factors among persons with no clinical signs of cardiovascular diseases. Material and methods. In the study, 92 Moscow and Moscow Region inhabitants included, men and women at age 25-76 y.o., with no clinical signs of chronic non-infectious diseases, not taking any medications, but with probable existence of cardiovascular risk factors. All participants underwent prescreening investigation that included physical examination, clinical and biochemical blood collection, electrocardiography, thread-mill test, risk factors assessment, and sequencing of the variable loci V3-V4 of the gene 16S of rRNA of gut microbiota. Results. During the study, it was revealed that in the studied cohort there were more opportunistic bacteria in the donors having risk factors: Serratia — in obese and glucose metabolism disorder, Prevotella — in obese, disordered glucose metabolism and raised systolic pressure, Blautia — glucose metabolism disorder and raised systolic pressure. Amylolytic bacteria Oscillosipa were less common in obese. Conclusion. The dysbalance of gut microbiota with riased level of opportunistic bacteria that potentially initiate systemic non-specific inflammation, is associated with the existence of cardiovascular risk factors.

Facteurs de risque cardiovasculaires associés au dysfonctionnement érectile dans la région de Dakar, Sénégal

BackgroundErectile dysfunction (ED) is often a reason for consultation revealing the existence of cardiovascular risk factors. The objective of this study was to determine the cardiovascular risk factors associated with ED in the Dakar region. MethodsA descriptive and analytical cross-sectional study was conducted from March 18 to June 2, 2013. The study population was composed of married male subjects who sought care at the Ouakam Geriatric and Gerontology Center and the Grand Yoff General Hospital. Erectile function was assessed with the International Index of Erectile Function using the simplified five-item questionnaire (IIEF 5). R 2.2.9 software was used for the logistic regression multivariate analysis. Associations were measured using the adjusted odds ratio (ORaj) with confidence intervals. ResultsA total of 253 men were surveyed during this period. Average age was 16.7±58.2 years, range 24–90 years; 47% were aged under 60 years. ED was diagnosed in 110 patients (43.5%). ED was considered mild (33.6%), moderate (5.5%) or severe (4.3%). ED was more severe in patients older than 60 years. Cardiovascular risk factors associated with ED were diabetes ORaj=2.4 (1.24–4.68), sedentary lifestyle ORaj=3.08 (1.69–5.61), and hypertension ORaj=2.53 (1.33–4.81). ConclusionThese results should prompt health care providers to target patients with diabetes, hypertension and sedentary lifestyle for systematic ED screening as a routine practice in order to ensure early and effective care.

Cardiovascular risk factors and physical activity among university students in Somaliland.

Physical inactivity is a well-known risk factor for the development of cardiovascular diseases and counts as fourth leading cause of death worldwide. The study aimed to elucidate to what extent cardiovascular risk factors exist in university students in Somaliland. In a cross-sectional survey, self-administered questionnaires were used to elucidate existence of cardiovascular risk factors in 173 university students (117 male, 56 female) in Hargeisa, Somaliland. Information elucidated included socio-economic and demographic data in addition to questions on coffee intake, on physical activity behavior, type of sport/activity and intensity and duration. Height and weight were taken, as was blood pressure (BP). Median age was 23 years in male and 20 years in female students. Mean BMI was 19.7 in male and 21.8 in female students. The prevalence rates of elevated BP and overweight (BMI ≥ 25) in female and male students were, 0 versus 9 and 14 versus 7 %, respectively. Coffee consumption was reported by 39 % of students. None of the female students reported smoking cigarettes, while 5.1 % of the male students did. Physical inactivity was reported by 52 % of the female students and 27 % of the male students (p = 0.01). Overall, male students reported a higher degree and intensity of physical activity. The prevalence of cardiovascular risk factors is low in female and male university students in Somaliland. However, the results demonstrate a high degree of physical inactivity and overweight might become a problem in the future. This issue should be addressed by increasing the motivation and opportunities for physical activity in students.

RVO related macular edema: Rules for the patients follow up; how to choose the applied treatment?

AbstractThe treatment of RVO has dramatically evolved during the last few years. The main evidence base therapies are antiVEGF agents (Ranibizumab, Aflibercept, and level 2 evidence for bevacizumab) and steroids (Ozurdex). Each approach has advantages and limitations, while both have good efficacy results. In the decision making of the needed treatment inflammatory as well as VEGF pathways need to be taken into consideration. The treatment is to be tailored to the individual patient taking into consideration both ocular (existence of glaucoma, if it is controlled, existence of cataract, pseudophakia, ischemia), systemic (existence of cardiovascular risk factors) and social (ability to come monthly and availability of the health care system). Results of head to head trials are awaited.

Cardiovascular effects of resveratrol

nema